다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
BioNexus Gene Lab Corporation (BGLC)
BioNexus Gene Lab Corporation (BGLC) 뉴스

BGLC

BioNexus Gene Lab (BGLC)

BioNexus Gene Lab Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BGLC

1

일자	시간	출처	헤드라인	심볼	기업
2024/06/01	04:47	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04:46	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04:46	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04:45	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/06/01	04:45	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/05/10	01:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/04/19	03:52	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/01/27	06:05	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2024/01/23	21:55	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/11/03	23:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/09/08	00:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/25	06:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/25	00:30	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market	NASDAQ:BGLC	BioNexus Gene Lab Corporation
2023/07/21	02:29	GlobeNewswire Inc.	BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market	NASDAQ:BGLC	BioNexus Gene Lab Corporation

검색 관련기사 보기:NASDAQ:BGLC

1

JP Morgan Chase

US Dollar vs Euro

US Dollar vs Yen

Bank of America

Gold vs US Dollar

US Dollar vs Sterling

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관